Joel Greenblatt Gain Therapeutics, Inc. Transaction History
Gotham Asset Management, LLC
- $16.1 Billion
- Q2 2025
A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Gain Therapeutics, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 245,896 shares of GANX stock, worth $376,220. This represents 0.0% of its overall portfolio holdings.
Number of Shares
245,896
Previous 153,984
59.69%
Holding current value
$376,220
Previous $294,000
50.34%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding GANX
# of Institutions
37Shares Held
4.57MCall Options Held
37.9KPut Options Held
0-
Jones Financial Companies Lllp677KShares$1.04 Million0.0% of portfolio
-
David Einhorn Greenlight Capital Inc | New York, Ny588KShares$900,2670.1% of portfolio
-
Dme Capital Management, LP New York, NY566KShares$866,1780.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA534KShares$817,5580.0% of portfolio
-
Geode Capital Management, LLC Boston, MA290KShares$444,4060.0% of portfolio
About Gain Therapeutics, Inc.
- Ticker GANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,883,400
- Market Cap $18.2M
- Description
- Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietar...